Come up with a name for your new list and we'll add to it:
Affymax was acquired by
MPM Capital and
Sprout Group on August 15, 2001.
Affymax is a biopharmaceutical company committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. The companys product candidate, Hematide, is curre…